This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
March 15, 2017
Targovax ASA: Annual Report 2016
March 14, 2017
Strongbridge Biopharma plc to Present at the 27th Annual Oppenheimer Healthcare Conference and the 16th Annual Needham Healthcare Conference
March 13, 2017
MIPS announces its intention to list its shares on Nasdaq Stockholm
March 13, 2017
GenSight Biologics Reports Full Year 2016 Financial Results
March 08, 2017
Nexstim Plc announces signing of an Independent Selling Representative Agreement in the U.S. with Surgical Solutions, Inc.
March 07, 2017
Nexstim Plc Announces the Start of Patient Enrolment in the Supplementary Phase III Trial in Stroke Rehabilitation with its NBT system
March 06, 2017
NEXSTIM PLC PUBLISHES 2016 ANNUAL REPORT
March 06, 2017
Targovax to present at upcoming conferences
March 01, 2017
Cerenis Therapeutics Announces Top line Results of CARAT Phase II Study – No statistical difference observed between CER-001 and placebo
March 01, 2017
Orexo commences patent infringement litigation against Actavis for their generic versions of Suboxone® and Subutex® tablets in the US